If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

October 16, 2023
Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » Clinical Trials Search » Investigational Inhibitor of Active RAS Shows Clinical Promise – Alexander I. Spira, MD, PhD, FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise –  The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C

 thumbnail of Targets23_Spira_RasON_FINAL

Alexander I Spira MD, PhD, FACP, FASCO Headshot

Alexander I Spira MD, PhD, FACP, FASCO

Medical Oncologist

Recent Posts

Join the Virginia Cancer Specialists Team at the 2025 Multiple Myeloma Research Foundation Walk/Run
Join the Virginia Cancer Specialists Team at the 2025 Multiple Myeloma Research Foundation Walk/Run
August 26, 2025
Read More
Research is Hope. Hope for Today. Hope for Tomorrow.
Research is Hope. Hope for Today. Hope for Tomorrow.
August 7, 2025
Read More
Advancing Sarcoma Surgery: A Surgeon’s Perspective - Felasfa M. Wodajo, MD
Advancing Sarcoma Surgery: A Surgeon’s Perspective - Felasfa M. Wodajo, MD
July 15, 2025
Read More
New Mobile Pay Options
New Mobile Pay Options
July 8, 2025
Read More
Virginia Cancer Specialists Expands and Rebrands Its Palliative Care Program to Support Patients through Every Step of Cancer Treatment
Virginia Cancer Specialists Expands and Rebrands Its Palliative Care Program to Support Patients through Every Step of Cancer Treatment
July 8, 2025
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top